SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin

Clinical trial NCT07560566 · RECRUITING

Trial details

NCT number: NCT07560566
Sponsor: National Taiwan University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)Hand Foot Skin Syndrome

Start date: 2025-12-09
Primary completion: 2029-04-30
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.